Last C$2.39 CAD
Change Today -0.03 / -1.24%
Volume 233.5K
NTB On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
Toronto
As of 4:00 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

neptune tech & bioressources (NTB) Snapshot

Open
C$2.38
Previous Close
C$2.42
Day High
C$2.40
Day Low
C$2.27
52 Week High
08/13/13 - C$4.35
52 Week Low
07/30/14 - C$2.27
Market Cap
176.4M
Average Volume 10 Days
91.5K
EPS TTM
C$-0.36
Shares Outstanding
73.8M
EX-Date
07/24/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEPTUNE TECH & BIORESSOURCES (NTB)

Related News

No related news articles were found.

neptune tech & bioressources (NTB) Related Businessweek News

No Related Businessweek News Found

neptune tech & bioressources (NTB) Details

Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company is also developing CaPre, which is in Phase II clinical trials for the management of mild to moderate hypertriglyceridemia and severe hypertriglyceridemia, as well as develops and commercializes pharmaceutical applications for cardiovascular and neurological diseases. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.

118 Employees
Last Reported Date: 07/15/14
Founded in 1925

neptune tech & bioressources (NTB) Top Compensated Officers

Interim Chief Executive Officer, Interim Pres...
Total Annual Compensation: C$164.1K
Chief Global Strategic Officer
Total Annual Compensation: C$196.0K
Chief Operating Officer of Acasti
Total Annual Compensation: C$19.9K
Senior Vice-President of Global Sales
Total Annual Compensation: C$175.2K
Compensation as of Fiscal Year 2014.

neptune tech & bioressources (NTB) Key Developments

Neptune Technologies & Bioressources, Inc. Announces Consolidated Earnings Results for the First Quarter Ended May 31, 2014

Neptune Technologies & Bioressources, Inc. announced consolidated earnings results for the first quarter ended May 31, 2014. For the period, the company's consolidated revenues totaled $3,691,000, down from $6,090,000 for the quarter ended May 31, 2013. Adjusted LBITDA was $5,772,000 against $3,983,000 in the prior year. Net loss was $4,368,000 against $5,415,000 in the prior year. The year over year decrease in adjusted EBITDA on both a nutraceutical and consolidated basis is largely due to higher general and administrative expenses, including salaries, training costs associated with the reopening of the Sherbrooke plant and a bad debt charge for one significant customer. On a consolidated basis, the year over year quarterly net loss was lower due to a change in the fair value of Acasti's derivative warrant liability arising from its 2013 public offering.

Neptune Technologies & Bioressources, Inc., Q1 2015 Earnings Call, Jul 17, 2014

Neptune Technologies & Bioressources, Inc., Q1 2015 Earnings Call, Jul 17, 2014

Neptune Technologies & Bioressources, Inc. Announces Changes to Board of Directors

Neptune Technologies & Bioressources, Inc. that at its Annual and Special Meeting held on June 19, 2014, the corporation's shareholders elected Mr. Pierre Fitzgibbon, Mr. Adrian Montgomery, Mr. John Moretz and Mr. Jerald J. Wenker as four new directors. Mr. Henri Harland and Mr. Daniel Perry did not stand for re-election to the Board. Mr. Perry resigned from the Board on June 18, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTB:CN C$2.39 CAD -0.03

NTB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Badger Meter Inc $50.14 USD +0.09
Enzymotec Ltd $14.96 USD +0.12
Itron Inc $36.90 USD +0.57
Targeted Medical Pharma Inc $0.73 USD -0.1075
View Industry Companies
 

Industry Analysis

NTB

Industry Average

Valuation NTB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.4x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit www.neptunebiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.